ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4 (toll-like receptor 4) . ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
394.63
Molecular Formula
C11H9BrClN3O4S
Notes
Research use only, not for human use.
Receptor
TLR
CAS Number
1638200-22-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1141377-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus Putative Holliday junction resolvase (BCAH820_4466)
Ask
View Details MBS1141377-02 0.1 mg (E-Coli)
Recombinant Bacillus cereus Putative Holliday junction resolvase (BCAH820_4466)
Ask
View Details